Glide Pharma Announces Design Optimization Agreement With Nypro Healthcare
Glide Pharma recently announced it has entered an agreement with global device manufacturer Nypro Healthcare to complete the design optimization of its solid dose injector in preparation for production scale up. The company’s delivery system, the Glide SDI, is a unique technology for injecting drugs and vaccines in a solid dosage form without the need for a needle. The Glide SDI comprises a novel tiny solid dosage, which is pushed into the skin with a small, hand-held, spring-powered device. Nypro Healthcare will work with Glide Pharma to ensure the design of the device and its components are optimized for manufacturing scale up and to ensure patient requirements, including self-administration, are met.
“This agreement marks a milestone for our Glide SDI device as it will enable us to complete the final phase of development prior to production scale up. As a recognized leader in the development and manufacturing of precision devices, we believe that Nypro Healthcare is the perfect partner to work with Glide Pharma on advancing our novel delivery system,” said Dr. Mark Carnegie-Brown, CEO, Glide Pharma.
“The Glide SDI is a highly innovative delivery system, which is very different from other technologies currently on the market. Nypro Healthcare is delighted to have been selected as Glide Pharma’s partner to help progress the development of this exciting new technology,” added Chris Nother, VP Business Development, Nypro Healthcare.
The Glide SDI is an innovative needle-free delivery system. The reusable injector uses a spring mechanism to administer a tiny solid dosage below the patient’s skin, where it dissolves and releases the pharmaceutical. Glide’s solid dose formulations eliminate the risk of needle-stick injuries and avoid time-consuming reconstitution. They also have the potential to modify the release of medicines and to improve stability, removing the need for refrigeration. The one-click action, pen-sized device is extremely easy to use, with medicines supplied in prefilled disposable cassettes, making it ideal for self-administration. In clinical testing, volunteers strongly preferred the Glide SDI to traditional needle and syringe.
Glide Pharma is a pharmaceutical development and device company focused on the easy, safe, and convenient administration of solid dose formulations of therapeutics and vaccines. For more information, visit www.glidepharma.com.
Nypro Healthcare is a provider of device development and global manufacturing services to the world’s leading and emerging pharmaceutical, diagnostics and medical device companies, supporting from concept, through clinical trials and into commercial production. For more information, visit www.nypro.com.
Total Page Views: 1166
